Stay updated on 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial

Sign up to get notified when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T02:15:09.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    An NIH site announcement explains that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-25T02:07:24.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:57:28.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-11T02:28:58.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study record history now shows a new Revision: v3.7.0, replacing the previous v3.6.6, indicating an update to the history-tracking interface.
    Difference
    0.1%
    Check dated 2026-09-20T01:10:18.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The revision history now includes a new entry for v3.6.6 and removes the previous v3.6.5, reflecting an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-08-29T20:54:31.000Z thumbnail image

Stay in the know with updates to 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.